How can we differentiate Chronic Lymphocytic Leukemia (CLL) from other B-Cell Lymphoid Malignancies? The availability of a clinical decision algorithm for the diagnosis of Chronic Lymphocytic Leukemia (CLL) may greatly contribute to not only the diagnosis of CLL but also to differentiations of lymphoid lineage malignancies, particularly in cases with ambiguous immunophenotypes. This edition of our QSP newsletter provides insights into revisiting Chronic Lymphocytic Leukemia (CLL) increased specificity for diagnosis and further differentiation by Matutes Score.
► Read the QSP Newsletter #41
► Visit QSP Newsletter page
QSP Newsletter is based on the monthly case studies provided in HORIBA Medical’s QSP program for helping laboratories to update themselves quickly with important and unique real Hematology cases from around the world.
